Proton Sponge Phosphanes
and [Ru(p-cymene)Cl2]2 (0.101 g, 0.165 mmol) was refluxed for 3 h crystals of trans-[PdCl2(3a)2] and a small quantity of yellow crystals
with monitoring (ESI-MS), after which time the reaction was
judged to be complete (absence of free 3a). The solution was left
to stand for 2 d, reduced in volume and layered with pentane.
Crystallizations were set up, eventually the product decomposed to
black oil. ESI-MS (after 2 h reflux, MeOH, selected peaks): m/z
(%) = 634.94 (40) [Ru(η6-p-cymene)(3a) + H]+, isotope model
(635.22), 874.53 (3) [Ru2(η6-p-cymene)(MeOH)Cl3(3a)]+, isotope
model (875.05). MS/MS (635) [Ru(η6-p-cymene)(3a) + H]+): m/z
(%) = 496.41, 457.35, 379.10, 298.81 (major Ru species) and 197.70
of [Pd2Cl4(3a)2] slowly formed at the interface. The orange crystals
proved to be highly insoluble in most solvents and only sparingly
soluble in CH2Cl2. Yellow crystals of [Pd2Cl4(3a)2] were completely
soluble in CH2Cl2. M.p. ([PdCl2(3a)2]) 178–186 °C (decomp.),
m.p. ([Pd2Cl4(3a)2]): 198 °C (decomp.). PdCl2(3a)2·CH2Cl2:
C53H56Cl4N4P2Pd: calcd. C 60.22, H 5.34, N 5.30, P 5.87; found C
59.95, H 5.39, N 5.14, P 5.64. 31P NMR (CDCl3, 202 MHz): δP
=
1
42.80 {s, [Pd2Cl4(3a)2]}, trace 32.82 (s, trans-[PdCl2(3a)2]) ppm. H
NMR (CDCl3, 500 MHz): δH = 7.81 (ddd, JHP = 13.1, JHH = 8.3,
1.0 Hz, 4 H, 12-H), 7.75 (dd, J = 7.7, 1.5 Hz, 1 H, 5-H or 7-H)
7.71 (dd, J = 8.5, 1.6 Hz, 1 H, 4-H), 7.67 (dd, J = 7.5, 1.5 Hz, 1
H, 5-H or 7-H), 7.62 (dd, J = 7.7 Hz, 1 H, 6-H), 7.57 (t, 2 H, 14-
([M
–
CH4]+, model 198.11). MS/MS (874), [Ru2Cl3(η6-p-
cymene)(3a)MeOH]+: m/z (%) = 872.56, general Ru “grass” be-
tween 800 and 400, 213.8 ([M – H]+, model 213.14).
H), 7.47 (td, JHH = 8.8, JHP = 3 Hz, 4 H, 13-H), 7.07 (dd, JHP
=
Reaction of [Ru(p-cymene)Cl2]2 with 3a in MeCN/toluene: The com-
pounds 3a (13 mg, 0.033 mmol) and [Ru(p-cymene)Cl2]2 (10 mg,
0.017 mmol) were placed in a flask, which was evacuated and
placed under N2. CD3CN (1 mL) was added, the solution mixed
9.4, JHH = 8.5 Hz, 1 H, 3-H), 4.19 (s, 6 H, NMe2), 2.62 (s, 6 H,
NMe2) ppm. Major impurity: 6.28 (m, cod, 2.5 H), 5.56 (m, cod, 2
H), 2.35 (m, cod, 4 H) ppm. ESI-MS (CH2Cl2/formic acid) selected
peaks: m/z (%) = 974.89 (0.2%, [PdCl2(3a)2 + H]+, model 975.23),
581.88 (0.35%, [MeCN·PdCl(3a)]+, model 582.08), 485.95 (0.08%,
[PdCl2(3a)2 – 2H]2+, model 486.94). MS/MS (974): m/z (%) =
974.91 ([PdCl2(3a)2 + H]+), 399.09 [3a +H]+. ESI-MS (yellow crys-
tals) (MeOH/DCM) selected peaks: m/z (%) = 1114.84 (100%,
[Pd2Cl3(3a)2]+, model 1115.10), 1078.89 (2%, [Pd2Cl2(3a) – H]+,
model 1079.12), 538.94 (100%, [PdCl·3a]+, model 539.07).
and filtered into an NMR tube. The reaction was monitored by 31
P
1
1
and H NMR at regular intervals. 31P NMR yield 80%. H NMR
(360 MHz, CD3CN, [Ru(η6-p-cymene)Cl2]2): δH = 5.54 (d, J =
6.1 Hz, 4 H, AriPr), 5.29 (d, J = 6.2 Hz, 4 H, ArMe), 2.90 (septet,
J = 7.0 Hz, 2 H, HiPr), 2.22 (s, 6 H, Me), 1.29 [d, J = 7.0 Hz, 12
H, 2(iPr)Me] ppm. 13C NMR {90 MHz, CD3CN, [Ru(η6-p-
cymene)Cl2]2}: δC = 103.52 (quat, AriPr), 99.99 (quat, ArMe), 84.63
(ArMe), 82.21 (AriPr), 31.79 (secondary iPr), 22.38 (iPrMe), 18.96
(Me) ppm. Main product, [Ru(p-cymene)(Cl)(3a)][Cl]. 31P NMR
(red crystals, 146 MHz, CD3CN): δ = 52.69 (s) ppm. 1H NMR
(360 MHz, CD3CN): δH = 7.85 [ddd, J = 11.3, 1.1, 8.3 Hz, 2 H,
H12, NOE to p-cymene (5.07)], 7.71–7.49 (m, 12 H, 1 5-H, 1 4-H,
2 12Ј-H, 2 13-H & 2 13Ј-H, 1 14-H & 1 14Ј-H, 6-H, 7-H) ppm.
Within this: 7.54–7.58 (4-H), 7.28–7.16 (m, impurity, 2 H), 7.12
(dd, 1 H, J = 8.4, 9.6 Hz, coupling to 31P, H3), 6.28 (dd, J = 7,
1 Hz, 1 H, p-cymene ring, NOE to iPr group at 1.22 and 6.07),
6.25 (dd, J = 5.2, 1 Hz, 1 H, p-cymene ring, NOE to 5.07 and Me
at 1.53), 6.07 (dd, J = 6.3, 1 Hz, 1 H, p-cymene ring, NOE to Me
group at 4.02 and Me group at 1.53), 5.07 (dd, J = 6.0, 1.5 Hz, 1
H, p-cymene ring, NOE to iPr CH group and 6.25, NOE to H12 at
7.85), 4.18 [d, J = 0.5 Hz, 3 H, NMe group, on C1back, NOE to
6.07 (weak) and 6.25 p-cymene proton], 4.02 (s, 3 H, Me, NMe
group, on C1front, NOE to 6.07 p-cymene, NOE to p-cymene Me at
1.53), 2.90 (s, 3 H, NMe group on C8back, NOE to NMe at 4.18
and weak NOE to NMe at 4.02), 2.78 (septet, J = 6.9 Hz, 1 H, iPr
CH, NOE to both 1.22 and 1.18, and 5.07), 2.27 (s, NMe group
on C8front, 3 H, NOE to Ar-CH3 at 1.53, strong NOE to NMe on
C8back at 2.90, very weak NOE to 7-H), 1.53 (s, Ar-CH3 group,
NOE to 6.25 and 6.07), 1.22 (d, J = 6.7 Hz, 3 H, iPr CH3 group,
NOE to 2.78), 1.18 (d, J = 6.9 Hz, 3 H, iPr CH3 group, NOE to
2.78). ESI-MS: m/z (%) = 669.16 (100%) ([Ru(η6-p-cymene)Cl-
(3a)]+ model 669.18). MS/MS (669): m/z (%) = 669.97 ([Ru(η6-p-
cymene)Cl(3a)]+), 536.52 ([RuCl(3a)]+ model 535.07), 482.36,
197.70 ([1a-CH3]+, model C13H13N2 197.11).
Synthesis Using 3a·HBr: ESI-MS (orange product): m/z (%) =
376.10 (1%, [“Pd”]2+), 397.19 [5%, (3a – H)]+, 399.20 [1%, (3a
+ H)]+, 486.11 (3%, [PdCl2(3a – H)2]2+, model C52H52Cl2N4P2Pd,
486.61), 575.03 (4%, [PdCl2(3a – H)]+, model C26H26Cl2N2PPd,
575.03), 607.05 (2%), [PdCl2(3a) + 31]+, 774.12 (0.5%, [Pd2Cl4(3a –
H)2(3a)]2+
, model C78H79Cl4N6P3Pd2, 774.62), 791.10 (0.2%
[“Pd”]2+), 827.05 (0.2% [“Pd2”]2+), 844.05 (0.3%, [“Pd2”]2+),
863.03 (0.3%, [“Pd2”]2+), 880.00 (3%, [Pd3Cl7(3a – H)3]2+, model
880.52), 933.45 (0.1%, [“Pd2”]2+).
Synthesis of PtCl2(3a)2: A solution of 3a (43 mg, 0.11 mmol) in
diethyl ether (1.1 mL) was added to
a stirring solution of
PtCl2(cod) (20 mg, 0.054 mmol) in CH2Cl2 (0.7 mL). The pale yel-
low solution intensified in color on stirring for 6 h after which time
stirring of the solution was stopped and ether was carefully layered
onto the solution which was left overnight. Microcrystalline yellow
PtCl2(3a)2 was recovered in two successive crops by filtration and
washing with ether: yield 23 mg, 41%, m.p. 236–240 °C (decomp).
31P NMR (400 MHz, CDCl3): δP = 15.6 (1JPPt = 3900 Hz) ppm. 1H
NMR (400 MHz, CDCl3): δH = 7.79 (m, 10 H, 8 12-H plus 2 4-
H), 7.71 (d, J = 2, 8 Hz, 2 H, 5-H or 7-H), 7.69 (d, J = 8, 2 Hz, 2
H, 5-H or 7-H), 7.62 (t, J = 7.6 Hz, 2 H, 2 6-H), 7.54 (m, 4 H, 4
14-H), 7.45 (t with 31P coupling, 8 13-H), 7.20 (dd, J = 8, 9 Hz, 2
H, 3-H), 4.40 [s, 6 H, N(CH3)2, 1-H or 8-H], 2.62 [s, 6 H,
N(CH3)2, 1-H or 8-H] ppm. ESI-MS (of crude solution, CH2Cl2):
m/z (%) = 398.89 (100%, [3a + H]+), 1062.58 (15%, [PtCl2(3a)2 +
H]+) and trace amounts (Ͻ1%) of: [PtCl(3a)2]+ (1026.65, 0.5%),
dimer at 1726.23 (model Pt2Cl4(3a)3H = 1727.38). MS/MS of
[PtCl2(3a)2 + H]+ gave exclusively free [3a + H]+ at 399.03. MS/
MS of the dimer at 1726 gave [PtCl2(3a)2 + H]+ and [3a + H]+
only.
Reaction Between [Ru(p-cymene)Cl2]2 and Protonated Ligand
3a·HBF4: The reaction was repeated by stirring at room tempera-
ture in MeCN with the protonated ligand 3a·HBF4 overnight. The
only new 31P signal detected was due to the intermediate (pos-
tulated to be the dimer) not the final product monomer. 31P NMR
(121 MHz, CD3CN): δP = –18.32 (s, 3a·HBF4, integral 35), 31.97
(s, integral 1) ppm.
CCDC-837948 (for 3a) and CCDC-837947 (for 3b) contain the
supplementary crystallographic data for this paper. These data can
be obtained free of charge from The Cambridge Crystallographic
Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
Crystalline trans-PdCl2(3a)2 (Orange) with Crystalline Pd2Cl4(3a)2
(Yellow): A yellow solution of 3a (100 mg, 0.25 mmol) in dry ether
(0.5 mL) was layered onto a solution of [Pd(COD)Cl2] (20 mg,
0.07 mmol) in dry CH2Cl2 (0.5 mL) in a narrow glass tube. Orange
Supporting Information (see footnote on the first page of this arti-
1
cle): Additional ESI-MS(/MS) and H NMR spectra.
Eur. J. Inorg. Chem. 2012, 733–740
© 2012 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjic.org
739